Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;27(2):279-283.
doi: 10.5853/jos.2024.05113. Epub 2025 May 31.

Early Administration of Nelonemdaz May Improve the Stroke Outcomes in Patients With Acute Stroke

Affiliations

Early Administration of Nelonemdaz May Improve the Stroke Outcomes in Patients With Acute Stroke

Jin Soo Lee et al. J Stroke. 2025 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

Dr. Jin Soo Lee reported receiving grants and personal fees from GNT Pharma outside the submitted work. Dr. Ji Sung Lee reported receiving personal fees from GNT Pharma during the conduct of the study. Dr. D. Choi reported receiving personal fees from GNT Pharma during the conduct of the study. Dr. Byoung Joo Gwag is the Chief Executive Officer and Dr. Chun San An is the Clinical Development Officer of GNT Pharma. No other disclosures were reported related to the submitted work.

Figures

Figure 1.
Figure 1.
Distribution of the modified Rankin Scale (mRS) scores at 12 weeks in (A) unadjusted and (B) adjusted populations, respectively.

References

    1. Lee JS, Kang HG, Ahn SH, Song TJ, Shin DI, Bae HJ, et al. Nelonemdaz and patients with acute ischemic stroke and mechanical reperfusion: the RODIN randomized clinical trial. JAMA Netw Open. 2025;8:e2456535. - PMC - PubMed
    1. Hong JM, Lee JS, Lee YB, Shin DH, Shin DI, Hwang YH, et al. Nelonemdaz for patients with acute ischemic stroke undergoing endovascular reperfusion therapy: a randomized phase II trial. Stroke. 2022;53:3250–3259. - PMC - PubMed
    1. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22:391–397. - PubMed
    1. Choi DW. Ionic dependence of glutamate neurotoxicity. J Neurosci. 1987;7:369–379. - PMC - PubMed
    1. Gwag BJ, Lee YA, Ko SY, Lee MJ, Im DS, Yun BS, et al. Marked prevention of ischemic brain injury by Neu2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine. J Cereb Blood Flow Metab. 2007;27:1142–1151. - PubMed

Grants and funding

LinkOut - more resources